Eloxx Pharmaceuticals Names T.R. Srinivas Chief Medical Officer
Bitget2026/10/20 13:33- Eloxx Pharmaceuticals appointed a Novartis executive as senior vice president and chief medical officer.
- The appointee’s Novartis responsibilities included U.S. medical affairs leadership for ADPKD product development.
- The new chief medical officer will oversee renal medical strategy across the Alport and ADPKD programs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Utexo Mint open beta: Get early access to USD₮ on the bitcoin blockchain
"Demand destruction" and tug-of-war over Saudi attack risks, international oil prices fall more than 2%
Traders weighed the impact of Saudi attack risks and sharply reduced demand, causing oil prices to fall more than 2%.
JPMorgan maintains "Neutral" rating on Johnson & Johnson (JNJ.US): Strong data from two anti-cancer drugs, but valuation premium limits upside potential
Johnson & Johnson’s new prostate cancer drug and head and neck cancer drug Ervantumab both released positive data at ESMO. JPMorgan stated that the pipeline shows differentiated potential but valuations are relatively high, maintaining a Neutral rating.
AI trading hype fades and product competition intensifies: SK Hynix (SKHY.US) leveraged ETF delisted from US stock market and liquidated just three months after launch
Two U.S. leveraged ETFs linked to SK Hynix (SKHY.US)—the Tradr 2X Long SK Hynix Daily ETF and the Tradr 2X Short SK Hynix Daily ETF—will be liquidated around November 12, approximately three months after their listing on July 28.
Crypto prices
More
